It binds with a high affinity to the canonical CGRPr receptor and antagonizes CGRPr function to provide migraine prevention to both EM and CM patients through blockage of both the CGRP and CLR/RAMP1 receptors within the trigeminal system. This evidence concerns the gene CALCA and migraine disorder.